+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Foot & Mouth Disease Vaccines Market by Animal Type, Vaccine Type, Formulation, End User, Route of Administration, Application, Distribution Channel - Global Forecast to 2030- Product Image
Foot & Mouth Disease Vaccines Market by Animal Type, Vaccine Type, Formulation, End User, Route of Administration, Application, Distribution Channel - Global Forecast to 2030- Product Image
Sale

Foot & Mouth Disease Vaccines Market by Animal Type, Vaccine Type, Formulation, End User, Route of Administration, Application, Distribution Channel - Global Forecast to 2030

  • PDF Icon

    Report

  • 186 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 4829815
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Foot & Mouth Disease Vaccines Market grew from USD 2.93 billion in 2024 to USD 3.21 billion in 2025. It is expected to continue growing at a CAGR of 9.13%, reaching USD 4.96 billion by 2030.

Understanding the Imperative of Foot & Mouth Disease Vaccination

Foot & Mouth Disease (FMD) remains a formidable threat to livestock health and agricultural economies worldwide. The disease’s capacity for rapid transmission among bovine, swine, sheep, and goats positions it as a critical concern for policymakers, veterinarians, and commercial producers. This executive summary introduces the major themes and findings of our comprehensive research, designed to equip decision-makers with the insights needed to anticipate market shifts and capitalize on emerging opportunities. We begin by outlining the underlying drivers of vaccine development and adoption, highlighting how global trade patterns, biosecurity mandates, and technological breakthroughs converge to shape the competitive environment.

As you navigate this summary, you will encounter a structured analysis of transformative shifts in the vaccine landscape, an evaluation of the United States tariff adjustments slated for 2025, and granular segmentation insights. Subsequent sections delve into regional performance, competitive dynamics among key manufacturers, and actionable recommendations for industry leaders. This introduction sets the context for a data-driven exploration that balances strategic perspective with tactical guidance. By synthesizing primary research, regulatory updates, and market intelligence, we provide a holistic view of the FMD vaccines market, empowering stakeholders to make informed, proactive decisions.

Emerging Dynamics Reshaping the FMD Vaccines Arena

Over the past decade, the FMD vaccine landscape has undergone profound transformation, driven by advances in molecular biology, cold-chain logistics, and digital surveillance. Innovations in subunit and recombinant technologies are reducing reliance on traditional inactivated formulations, offering higher safety margins and more precise antigen targeting. Meanwhile, the integration of multi-dosage platforms such as bivalent, quadrivalent, and trivalent polyvalent vaccines is enabling broader protection across viral serotypes, thereby streamlining immunization schedules and lowering per-animal costs.

Regulatory frameworks are also evolving in tandem. Harmonization efforts among international bodies are expediting product approvals, while risk-based trading protocols are incentivizing vaccine uptake in regions previously constrained by resource limitations. Concurrently, public-private partnerships are expanding production capacities and fostering technology transfer to emerging markets. Digital tools, including cloud-based temperature monitoring and blockchain-enabled traceability, are strengthening supply-chain integrity and end-user confidence. Taken together, these shifts are redefining competitive boundaries and creating new value pools for manufacturers and distributors alike.

Evaluating the Ripple Effects of 2025 US Tariff Adjustments

In 2025, a series of recalibrated tariff measures announced by the United States government will exert a cascading influence on the global FMD vaccine supply chain. The recalibration targets intermediate inputs used in manufacturing, potentially elevating raw material costs and compressing margins for producers reliant on imported antigens and adjuvants. As a result, manufacturers may need to reevaluate sourcing strategies and explore local partnerships in North America to mitigate heightened duties.

The new tariff environment also reshapes competitive positioning across regions. Export-oriented producers in Europe and Asia-Pacific may experience downward pricing pressure in the US market, compelling them to diversify into alternative geographies. Conversely, domestic vaccine producers in the United States stand to benefit from preferential treatment, gaining a cost advantage that could translate into increased market share. Trade policy uncertainty, however, underscores the importance of agile supply-chain management. Manufacturers that preemptively adjust procurement networks and engage proactively with customs authorities will be better positioned to stabilize pricing and maintain uninterrupted vaccine availability across key distribution channels.

Unveiling Granular Market Segmentation Patterns

The Foot & Mouth Disease vaccines market reveals distinct opportunities and challenges when examined through multiple segmentation lenses. Animal type segmentation highlights that the bovine population represents the largest share of demand, driven by stringent herd immunity targets and high economic value per head. Sheep and goats constitute a growth segment as small-ruminant producers increasingly adopt standardized vaccination protocols. Demand for swine vaccines, while historically moderate, is on an upward trajectory due to intensified biosecurity measures following recent outbreak events.

Vaccine type segmentation uncovers a transition from traditional inactivated vaccines toward live attenuated and subunit offerings, reflecting a growing appetite for formulations that balance efficacy with enhanced safety profiles. Formulation segmentation further emphasizes the rising popularity of polyvalent vaccines, particularly quadrivalent and trivalent versions, which streamline vaccination regimens and reduce logistical complexity compared to monovalent alternatives. End user segmentation shows that clinics and hospitals continue to dominate procurement volumes, although research institutes are emerging as influential adopters of novel vaccine technologies in pre-clinical settings.

Route of administration segmentation distinguishes injection as the conventional standard, but there is an increasing interest in oral delivery systems aimed at minimizing handling stress and labor costs. Application segmentation delineates preventive vaccination as the primary driver of market growth, while therapeutic applications are gaining traction in outbreak response scenarios. Distribution channel segmentation indicates that offline channels, including department stores, direct sales to veterinary networks, and specialty stores, remain the backbone of vaccine distribution. Simultaneously, online channels are expanding through company websites and e-commerce platforms, facilitating direct-to-farm sales and improved access in remote regions.

Regional Trajectories Shaping FMD Vaccine Demand

Regionally, the Americas lead in vaccine consumption and innovation, underpinned by advanced veterinary infrastructure, robust regulatory oversight, and substantial research investments. North America sets global standards in vaccine quality and cold-chain management, whereas Latin American markets are rapidly scaling up immunization programs to mitigate recurring outbreak risks. In the Europe, Middle East & Africa corridor, regulatory convergence within the European Union drives market consistency, while Middle Eastern and African nations show growing demand tied to livestock export ambitions and rising biosecurity awareness.

Asia-Pacific stands out as the fastest-growing region, propelled by large livestock populations in China, India, and Southeast Asian countries. National initiatives to bolster food security and rural incomes have elevated vaccination coverage rates, and domestic production capacities are expanding through joint ventures and technology licensing agreements. Infrastructure enhancements, including refrigerated storage networks and mobile veterinary services, further catalyze vaccine distribution to remote farming communities. Overall, regional distinctions underscore the importance of tailored market strategies that align with local regulatory environments, purchasing power, and disease prevalence patterns.

Competitive Landscape and Strategic Profiles

The competitive landscape is dominated by multinational pharmaceutical companies and specialized animal health firms, each leveraging distinct strategic assets. Leading players have invested heavily in research collaborations to accelerate subunit vaccine development and adjuvant innovation. They have also established regional manufacturing hubs to reduce lead times and circumvent trade barriers, particularly in North America and Asia-Pacific.

Mid-tier companies are differentiating themselves through niche product portfolios that focus on polyvalent and oral delivery systems, while smaller bioscience start-ups are targeting breakthrough technologies such as virus-like particles and mRNA-based formulations. Strategic alliances between established manufacturers and biotech innovators are becoming increasingly common, enabling rapid scale-up of novel vaccine candidates and sharing of regulatory risk. Beyond R&D, distribution partnerships with specialized veterinary networks and digital health platforms are broadening market reach. Companies that successfully integrate end-to-end capabilities-from pipeline discovery to last-mile delivery-are carving out sustainable competitive advantages in the evolving FMD vaccines space.

Strategic Imperatives for Market Leadership

Industry leaders should prioritize investment in advanced vaccine platforms that address multiple serotypes simultaneously, thereby reducing operational complexity and enhancing end-user adoption. Developing modular production facilities and flexible manufacturing lines will enable rapid response to outbreak demands and mitigate supply disruptions. In parallel, forging collaborative relationships with regulatory authorities can expedite approvals for innovative formulations and facilitate alignment on safety standards.

Strengthening digital distribution channels presents another critical imperative. Leveraging e-commerce and tele-veterinary services can extend market access to underserved regions, while integrated supply-chain monitoring tools enhance traceability and cold-chain compliance. Leaders must also invest in targeted educational outreach to veterinary professionals and producers, underscoring the cost-benefit advantage of early preventive vaccination. Finally, diversifying geographic exposure through strategic joint ventures and licensing agreements will hedge against localized regulatory and tariff risks, ensuring resilient growth pathways across all major markets.

Rigorous Methodological Framework Underpinning Insights

This research draws upon a rigorous multi-phase methodology designed to ensure accuracy and relevance. Primary data was collected through in-depth interviews with over 100 industry stakeholders, including vaccine manufacturers, regulatory experts, veterinary practitioners, and distribution partners. Secondary sources encompassed peer-reviewed journals, official trade and customs databases, policy white papers, and proprietary patents registries. Data triangulation techniques were applied to validate findings, while trend analysis and cross-referencing against historical outbreak records provided further contextual robustness.

Analytical frameworks included Porter’s Five Forces, SWOT assessments, and scenario planning to evaluate strategic options under varying regulatory and trade conditions. Geospatial mapping tools were utilized to visualize regional demand patterns, and cost-model simulations assessed the financial impact of tariff adjustments. Limitations of the study relate primarily to evolving policy environments and the inherent unpredictability of disease outbreaks, which could introduce variables outside the scope of current data. Nonetheless, ongoing surveillance and periodic model recalibration ensure that the insights presented remain grounded in the most recent market developments.

Synthesis of Critical Insights and Future Directions

Foot & Mouth Disease vaccines remain an essential pillar of global livestock health and agricultural stability. Through technological innovation, regulatory collaboration, and strategic market positioning, stakeholders have the opportunity to significantly reduce outbreak incidence and associated economic losses. The evolving landscape demands agility in sourcing, manufacturing, and distribution, with an emphasis on advanced formulations and integrated digital solutions.

Our analysis demonstrates that by leveraging granular segmentation insights and adapting to regional dynamics, vaccine providers can unlock new growth frontiers. Competitive differentiation will stem from pipeline innovation, scalable production, and targeted educational initiatives that foster end-user confidence. As 2025 draws near, the impact of tariff adjustments underscores the need for proactive supply-chain strategies. Ultimately, the confluence of scientific advancement and strategic foresight will define the next chapter in FMD vaccine development and deployment.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Animal Type
    • Bovine
    • Sheep And Goat
    • Swine
  • Vaccine Type
    • Inactivated Vaccine
    • Live Attenuated Vaccine
    • Subunit Vaccine
  • Formulation
    • Monovalent
    • Polyvalent
      • Bivalent
      • Quadrivalent
      • Trivalent
  • End User
    • Clinics
    • Hospitals
    • Research Institutes
  • Route Of Administration
    • Injection
    • Oral
  • Application
    • Preventive
    • Therapeutic
  • Distribution Channel
    • Offline
      • Department Stores
      • Direct Sales
      • Specialty Stores
    • Online
      • Company Websites
      • E-commerce Platforms
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Merck & Co., Inc.
  • Boehringer Ingelheim International GmbH
  • Zoetis Inc.
  • Ceva Santé Animale S.A.
  • Elanco Animal Health Incorporated
  • Indian Immunologicals Limited
  • Huvepharma AD
  • Laboratorios Hipra, S.A.
  • IDT Biologika GmbH
  • Phibro Animal Health Corporation

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Foot & Mouth Disease Vaccines Market, by Animal Type
8.1. Introduction
8.2. Bovine
8.3. Sheep and Goat
8.4. Swine
9. Foot & Mouth Disease Vaccines Market, by Vaccine Type
9.1. Introduction
9.2. Inactivated Vaccine
9.3. Live Attenuated Vaccine
9.4. Subunit Vaccine
10. Foot & Mouth Disease Vaccines Market, by Formulation
10.1. Introduction
10.2. Monovalent
10.3. Polyvalent
10.3.1. Bivalent
10.3.2. Quadrivalent
10.3.3. Trivalent
11. Foot & Mouth Disease Vaccines Market, by End User
11.1. Introduction
11.2. Clinics
11.3. Hospitals
11.4. Research Institutes
12. Foot & Mouth Disease Vaccines Market, by Route of Administration
12.1. Introduction
12.2. Injection
12.3. Oral
13. Foot & Mouth Disease Vaccines Market, by Application
13.1. Introduction
13.2. Preventive
13.3. Therapeutic
14. Foot & Mouth Disease Vaccines Market, by Distribution Channel
14.1. Introduction
14.2. Offline
14.2.1. Department Stores
14.2.2. Direct Sales
14.2.3. Specialty Stores
14.3. Online
14.3.1. Company Websites
14.3.2. E-commerce Platforms
15. Americas Foot & Mouth Disease Vaccines Market
15.1. Introduction
15.2. United States
15.3. Canada
15.4. Mexico
15.5. Brazil
15.6. Argentina
16. Europe, Middle East & Africa Foot & Mouth Disease Vaccines Market
16.1. Introduction
16.2. United Kingdom
16.3. Germany
16.4. France
16.5. Russia
16.6. Italy
16.7. Spain
16.8. United Arab Emirates
16.9. Saudi Arabia
16.10. South Africa
16.11. Denmark
16.12. Netherlands
16.13. Qatar
16.14. Finland
16.15. Sweden
16.16. Nigeria
16.17. Egypt
16.18. Turkey
16.19. Israel
16.20. Norway
16.21. Poland
16.22. Switzerland
17. Asia-Pacific Foot & Mouth Disease Vaccines Market
17.1. Introduction
17.2. China
17.3. India
17.4. Japan
17.5. Australia
17.6. South Korea
17.7. Indonesia
17.8. Thailand
17.9. Philippines
17.10. Malaysia
17.11. Singapore
17.12. Vietnam
17.13. Taiwan
18. Competitive Landscape
18.1. Market Share Analysis, 2024
18.2. FPNV Positioning Matrix, 2024
18.3. Competitive Analysis
18.3.1. Merck & Co., Inc.
18.3.2. Boehringer Ingelheim International GmbH
18.3.3. Zoetis Inc.
18.3.4. Ceva Santé Animale S.A.
18.3.5. Elanco Animal Health Incorporated
18.3.6. Indian Immunologicals Limited
18.3.7. Huvepharma AD
18.3.8. Laboratorios Hipra, S.A.
18.3.9. IDT Biologika GmbH
18.3.10. Phibro Animal Health Corporation
19. ResearchAI
20. ResearchStatistics
21. ResearchContacts
22. ResearchArticles
23. Appendix
List of Figures
FIGURE 1. FOOT & MOUTH DISEASE VACCINES MARKET MULTI-CURRENCY
FIGURE 2. FOOT & MOUTH DISEASE VACCINES MARKET MULTI-LANGUAGE
FIGURE 3. FOOT & MOUTH DISEASE VACCINES MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY VACCINE TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY VACCINE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY FORMULATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY FORMULATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 16. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 18. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 20. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. AMERICAS FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. AMERICAS FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. UNITED STATES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 24. UNITED STATES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. EUROPE, MIDDLE EAST & AFRICA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. EUROPE, MIDDLE EAST & AFRICA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. ASIA-PACIFIC FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 28. ASIA-PACIFIC FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 29. FOOT & MOUTH DISEASE VACCINES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 30. FOOT & MOUTH DISEASE VACCINES MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. FOOT & MOUTH DISEASE VACCINES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY BOVINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY SHEEP AND GOAT, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY SWINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY INACTIVATED VACCINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY SUBUNIT VACCINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY MONOVALENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY POLYVALENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY BIVALENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY QUADRIVALENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TRIVALENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY POLYVALENT, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY INJECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PREVENTIVE, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY THERAPEUTIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY OFFLINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DEPARTMENT STORES, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY SPECIALTY STORES, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY COMPANY WEBSITES, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY E-COMMERCE PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY POLYVALENT, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY POLYVALENT, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 61. UNITED STATES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 62. UNITED STATES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 63. CANADA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 64. CANADA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 65. CANADA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 66. CANADA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY POLYVALENT, 2018-2030 (USD MILLION)
TABLE 67. CANADA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 68. CANADA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 69. CANADA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 70. CANADA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 71. CANADA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 72. CANADA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 73. MEXICO FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 74. MEXICO FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 75. MEXICO FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 76. MEXICO FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY POLYVALENT, 2018-2030 (USD MILLION)
TABLE 77. MEXICO FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 78. MEXICO FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 79. MEXICO FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 80. MEXICO FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 81. MEXICO FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 82. MEXICO FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 83. BRAZIL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 84. BRAZIL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 85. BRAZIL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 86. BRAZIL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY POLYVALENT, 2018-2030 (USD MILLION)
TABLE 87. BRAZIL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 88. BRAZIL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 89. BRAZIL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 90. BRAZIL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 91. BRAZIL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 92. BRAZIL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 93. ARGENTINA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 94. ARGENTINA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 95. ARGENTINA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 96. ARGENTINA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY POLYVALENT, 2018-2030 (USD MILLION)
TABLE 97. ARGENTINA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 98. ARGENTINA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 99. ARGENTINA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 100. ARGENTINA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 101. ARGENTINA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 102. ARGENTINA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY POLYVALENT, 2018-2030 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 108. EUROPE, MIDDLE EAST & AFRICA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 109. EUROPE, MIDDLE EAST & AFRICA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 110. EUROPE, MIDDLE EAST & AFRICA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 111. EUROPE, MIDDLE EAST & AFRICA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 112. EUROPE, MIDDLE EAST & AFRICA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 113. EUROPE, MIDDLE EAST & AFRICA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 114. UNITED KINGDOM FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 115. UNITED KINGDOM FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 116. UNITED KINGDOM FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 117. UNITED KINGDOM FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY POLYVALENT, 2018-2030 (USD MILLION)
TABLE 118. UNITED KINGDOM FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 119. UNITED KINGDOM FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 120. UNITED KINGDOM FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 121. UNITED KINGDOM FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 122. UNITED KINGDOM FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 123. UNITED KINGDOM FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 124. GERMANY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 125. GERMANY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 126. GERMANY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 127. GERMANY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY POLYVALENT, 2018-2030 (USD MILLION)
TABLE 128. GERMANY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 129. GERMANY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 130. GERMANY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 131. GERMANY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 132. GERMANY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 133. GERMANY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 134. FRANCE FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 135. FRANCE FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 136. FRANCE FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 137. FRANCE FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY POLYVALENT, 2018-2030 (USD MILLION)
TABLE 138. FRANCE FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 139. FRANCE FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 140. FRANCE FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 141. FRANCE FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 142. FRANCE FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 143. FRANCE FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 144. RUSSIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 145. RUSSIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 146. RUSSIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 147. RUSSIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY POLYVALENT, 2018-2030 (USD MILLION)
TABLE 148. RUSSIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 149. RUSSIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 150. RUSSIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 151. RUSSIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 152. RUSSIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 153. RUSSIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 154. ITALY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 155. ITALY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 156. ITALY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 157. ITALY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY POLYVALENT, 2018-2030 (USD MILLION)
TABLE 158. ITALY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 159. ITALY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 160. ITALY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 161. ITALY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 162. ITALY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 163. ITALY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 164. SPAIN FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 165. SPAIN FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 166. SPAIN FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 167. SPAIN FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY POLYVALENT, 2018-2030 (USD MILLION)
TABLE 168. SPAIN FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 169. SPAIN FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 170. SPAIN FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 171. SPAIN FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 172. SPAIN FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 173. SPAIN FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 174. UNITED ARAB EMIRATES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 175. UNITED ARAB EMIRATES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 176. UNITED ARAB EMIRATES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 177. UNITED ARAB EMIRATES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY POLYVALENT, 2018-2030 (USD MILLION)
TABLE 178. UNITED ARAB EMIRATES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 179. UNITED ARAB EMIRATES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 180. UNITED ARAB EMIRATES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 181. UNITED ARAB EMIRATES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 182. UNITED ARAB EMIRATES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 183. UNITED ARAB EMIRATES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 184. SAUDI ARABIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 185. SAUDI ARABIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 186. SAUDI ARABIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 187. SAUDI ARABIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY POLYVALENT, 2018-2030 (USD MILLION)
TABLE 188. SAUDI ARABIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 189. SAUDI ARABIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 190. SAUDI ARABIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 191. SAUDI ARABIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 192. SAUDI ARABIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 193. SAUDI ARABIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 194. SOUTH AFRICA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 195. SOUTH AFRICA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 196. SOUTH AFRICA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 197. SOUTH AFRICA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY POLYVALENT, 2018-2030 (USD MILLION)
TABLE 198. SOUTH AFRICA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 199. SOUTH AFRICA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 200. SOUTH AFRICA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 201. SOUTH AFRICA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 202. SOUTH AFRICA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 203. SOUTH AFRICA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 204. DENMARK FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 205. DENMARK FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 206. DENMARK FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 207. DENMARK FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY POLYVALENT, 2018-2030 (USD MILLION)
TABLE 208. DENMARK FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 209. DENMARK FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 210. DENMARK FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 211. DENMARK FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 212. DENMARK FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 213. DENMARK FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 214. NETHERLANDS FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 215. NETHERLANDS FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 216. NETHERLANDS FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 217. NETHERLANDS FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY POLYVALENT, 2018-2030 (USD MILLION)
TABLE 218. NETHERLANDS FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 219. NETHERLANDS FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 220. NETHERLANDS FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 221. NETHERLANDS FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 222. NETHERLANDS FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 223. NETHERLANDS FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 224. QATAR FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 225. QATAR FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 226. QATAR FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 227. QATAR FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY POLYVALENT, 2018-2030 (USD MILLION)
TABLE 228. QATAR FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 229. QATAR FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 230. QATAR FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 231. QATAR FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 232. QATAR FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 233. QATAR FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 234. FINLAND FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 235. FINLAND FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 236. FINLAND FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 237. FINLAND FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY POLYVALENT, 2018-2030 (USD MILLION)
TABLE 238. FINLAND FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 239. FINLAND FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 240. FINLAND FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 241. FINLAND FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 242. FINLAND FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 243. FINLAND FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 244. SWEDEN FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 245. SWEDEN FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 246. SWEDEN FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 247. SWEDEN FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY POLYVALENT, 2018-2030 (USD MILLION)
TABLE 248. SWEDEN FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 249. SWEDEN FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 250. SWEDEN FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 251. SWEDEN FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 252. SWEDEN FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 253. SWEDEN FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 254. NIGERIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 255. NIGERIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 256. NIGERIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 257. NIGERIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY POLYVALENT, 2018-2030 (USD MILLION)
TABLE 258. NIGERIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 259. NIGERIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 260. NIGERIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 261. NIGERIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 262. NIGERIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 263. NIGERIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 264. EGYPT FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 265. EGYPT FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 266. EGYPT FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 267. EGYPT FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY POLYVALENT, 2018-2030 (USD MILLION)
TABLE 268. EGYPT FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 269. EGYPT FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 270. EGYPT FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 271. EGYPT FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 272. EGYPT FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 273. EGYPT FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 274. TURKEY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 275. TURKEY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 276. TURKEY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 277. TURKEY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY POLYVALENT, 2018-2030 (USD MILLION)
TABLE 278. TURKEY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 279. TURKEY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 280. TURKEY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 281. TURKEY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 282. TURKEY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 283. TURKEY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 284. ISRAEL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 285. ISRAEL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 286. ISRAEL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 287. ISRAEL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY POLYVALENT, 2018-2030 (USD MILLION)
TABLE 288. ISRAEL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 289. ISRAEL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 290. ISRAEL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 291. ISRAEL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 292. ISRAEL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 293. ISRAEL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 294. NORWAY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 295. NORWAY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 296. NORWAY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 297. NORWAY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY POLYVALENT, 2018-2030 (USD MILLION)
TABLE 298. NORWAY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 299. NORWAY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 300. NORWAY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 301. NORWAY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 302. NORWAY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 303. NORWAY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 304. POLAND FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 305. POLAND FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 306. POLAND FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 307. POLAND FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY POLYVALENT, 2018-2030 (USD MILLION)
TABLE 308. POLAND FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 309. POLAND FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 310. POLAND FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 311. POLAND FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 312. POLAND FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 313. POLAND FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 314. SWITZERLAND FOOT & MOUTH DISEASE VACCINES MARKET SIZE,

Companies Mentioned

The companies profiled in this Foot & Mouth Disease Vaccines market report include:
  • Merck & Co., Inc.
  • Boehringer Ingelheim International GmbH
  • Zoetis Inc.
  • Ceva Santé Animale S.A.
  • Elanco Animal Health Incorporated
  • Indian Immunologicals Limited
  • Huvepharma AD
  • Laboratorios Hipra, S.A.
  • IDT Biologika GmbH
  • Phibro Animal Health Corporation

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages186
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 3.21 Billion
Forecasted Market Value ( USD ) by 2030 $ 4.96 Billion
Compound Annual Growth Rate9.1%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Foot and Mouth Disease Vaccine Market Size, Share and Trends Analysis Report by Animal (Cattle, Sheep & Goat, Swine), Vaccine (Modified/Attenuated Live), Distribution Channel, and Region 2024-2030 - Product Image

Foot and Mouth Disease Vaccine Market Size, Share and Trends Analysis Report by Animal (Cattle, Sheep & Goat, Swine), Vaccine (Modified/Attenuated Live), Distribution Channel, and Region 2024-2030

  • Report
  • 100 Pages
  • Global
From
Foot and Mouth Disease Vaccine Market Report by Animal Type, Vaccine Type, Distribution Channel, and Region 2024-2032 - Product Image

Foot and Mouth Disease Vaccine Market Report by Animal Type, Vaccine Type, Distribution Channel, and Region 2024-2032

  • Report
  • 144 Pages
  • Global
From
Foot and Mouth Disease Vaccine Market Report 2025 - Product Image

Foot and Mouth Disease Vaccine Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Foot and Mouth Disease (FMD) Vaccine - Global Strategic Business Report - Product Image

Foot and Mouth Disease (FMD) Vaccine - Global Strategic Business Report

  • Report
  • 93 Pages
  • Global
From
Swine Vaccines Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Swine Vaccines Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 180 Pages
  • Global
From

About the Foot and Mouth Disease Vaccines Market

The Foot and Mouth Disease (FMD) Vaccines market is a segment of the Animal Pharmaceuticals industry. FMD is a highly contagious viral disease that affects cloven-hoofed animals, such as cattle, sheep, goats, and pigs. Vaccines are used to protect animals from the disease, and the FMD Vaccines market is composed of companies that produce and distribute these vaccines. Vaccines are typically administered through injection, and may be used to prevent outbreaks or to control existing outbreaks. The FMD Vaccines market is highly competitive, with a number of companies offering a variety of products. Companies in the market include Merck Animal Health, Boehringer Ingelheim, Elanco, Zoetis, and Ceva Sante Animale. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.